Inhibition of HIF-la activity is a novel strategy for the treatment of tubulointerstitial fibrosis
| Project/Area Number |
17590839
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Kidney internal medicine
|
|---|
| Research Institution | Nara Medical University |
|---|
Principal Investigator |
IWANO Masayuki Nara Medical University, First Department of Internal Medicine, Associate Professor, 医学部, 講師 (20275324)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SAITO Yoshihiko Nara Medical University, First Department of Internal Medicine, Professor, 医学部, 教授 (30250260)
AKAI Yasuhiro Nara Medical University, First Department of Internal Medicine, Associate Professor, 医学部, 講師 (30326326)
|
|---|
| Project Period (FY) |
2005 – 2006
|
| Project Status |
Completed (Fiscal Year 2006)
|
| Budget Amount *help |
¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 2006: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 2005: ¥2,000,000 (Direct Cost: ¥2,000,000)
|
|---|
| Keywords | hypoxia / interstitial fibrosis / renal failure / fibroblast / tubular epithelial cell / FSP1 / EMT / HIF-1α / YC-1 |
|---|
| Research Abstract |
Chronic hypoxia is a main contributor to the progression of tubulointerstitial fibrosis. In this study, we investigated the extent to which hypoxia-inducible factor 1α (HIF-1α) mediates epithelial-mesenchymal-transition (EMT) in vivo and in vitro using a mouse model in which renal proximal epithelial HIF-1α expression was selectively deleted and assessed the role of HIF-1α in EMT-mediated renal fibrosis. In addition, we developed a method with which to detect EMT in vitro, using Cre-recombinase activated β-galactosidase (LacZ) to identify and track primary tubular epithelial cells (TECs). To determine whether HIF-la is involved in the development of tubulointerstitial fibrosis in vivo, renal fibrosis was induced by unilateral urethral obstruction (UUO) in HIF-la-mutant and wild-type mice. Kidneys were harvested for immunohistochemistry 8 days after UUO and stained for FSP1 (fibroblast-specific protein 1, a marker for EMT) using a modified ABC-peroxidase method. Numbers of FSP1+ cells w
… More
ere significantly lower in obstructed kidneys from HIF-1α-mutant than wild type mice. Moreover, after exposure to hypoxia (1% O_2), but not normoxia (20.9% O_2), for 5 days cultured TECs permanently marked with LacZ assumed a fibroblast-like morphology. And double staining for LacZ and FSP1 revealed that whereas 8.2% of TECs underwent EMT (LacZ+/FSP1+) under normoxic conditions, 28.3% underwent EMT under hypoxic conditions. We also determined that blockade of HIF-1α activity can be a novel approach for the treatment of tubulointerstitial fibrosis through the inhibition of epithelial-mesenchymal-transition (EMT) in vitro and in vivo, using YC-1(3-(5'-hydroxymethy1-2'-fury1)-1-benzyl indazole) as an anti-HIF-1α agent.
Taken together, our results suggest that, through activation of HIF-1, hypoxia plays a key role in the induction of EMT and in EMT-mediated renal fibrosis in vitro and in vivo and anti-HIF-1α agents may be utilized for the treatment of tubulointerstitial fibrosis through the inhibition of EMT. Less
|
Report
(3 results)
Research Products
(7 results)
